Luise Froessl

ORCID: 0000-0003-0569-4278
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • T-cell and B-cell Immunology
  • Lymphoma Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • COVID-19 and healthcare impacts
  • Tracheal and airway disorders
  • Workplace Health and Well-being
  • Autoimmune Bullous Skin Diseases
  • COVID-19 Clinical Research Studies
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Lung Cancer Treatments and Mutations
  • COVID-19 and Mental Health
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Nanoplatforms for cancer theranostics
  • Immunotherapy and Immune Responses
  • Healthcare professionals’ stress and burnout
  • Vasculitis and related conditions
  • Pancreatitis Pathology and Treatment
  • Renal Diseases and Glomerulopathies
  • Esophageal and GI Pathology
  • Advanced Radiotherapy Techniques
  • Chemokine receptors and signaling
  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies

Southwestern Medical Center
2023-2024

The University of Texas Southwestern Medical Center
2023-2024

Pulmonary and Critical Care Associates
2021

Aix-Marseille Université
2021

Baylor College of Medicine
2021

Stanford University
2020

As SARS-CoV-2 continues to spread across the globe and significantly impacts health-care systems strains resources, identifying prognostic factors predict clinical outcome remains essential. We conducted a retrospective cohort study further explore value of serum hypoalbuminemia other in hospitalized COVID-19 patients. The primary endpoint was defined as risk in-hospital mortality. 300 patients were included analysis, with 56% being male mean (±SD) age 61.5 ± 15.3 years. albumin 2.86 0.5...

10.1155/2021/9963274 article EN cc-by Critical Care Research and Practice 2021-06-10

Abstract Nodular lymphocyte-predominant Hodgkin's lymphoma often follows an indolent course but carries a risk of late recurrence and transformation. Given its rarity, there is significant variability in the treatment patterns at various healthcare centers. This study aimed to compare patient characteristics outcomes NLPHL patients treated Parkland Health, safety-net system for uninsured/underinsured Dallas County with neighboring NCI-designated Harold C. Simmons Comprehensive Cancer Center...

10.21203/rs.3.rs-4131304/v1 preprint EN cc-by Research Square (Research Square) 2024-04-04

Abstract Background: Metastatic triple negative breast cancer (TNBC) is a diverse disease with the propensity to spread visceral organs and central nervous system (CNS). While systemic chemotherapy commonly used, there growing utilization of immune checkpoint inhibitors (ICI) antibody drug conjugates (ADC). However, few studies have examined impact specific therapies on individual metastatic sites, limiting clinical guidance for solitary metastases. Objective: This study aimed evaluate...

10.1158/1538-7445.sabcs23-po5-06-13 article EN Cancer Research 2024-05-02

We report the case of corneal transplant rejection in a 77-year-old male receiving durvalumab as consolidative therapy for stage IIIB non-small cell lung cancer (NSCLC). Following successful chemoradiation and initiation durvalumab, patient underwent right dystrophy. Six months after an initially stable post-transplant course, he developed progressive visual decline culminating graft failure 1 year later despite treatment with prednisone eye drops. This adds to limited evidence implicating...

10.1097/cji.0000000000000536 article EN Journal of Immunotherapy 2024-07-30

Although the incidence is declining in western world, Mycobacterium tuberculosis remains one of most common infectious organisms responsible for significant morbidity and mortality worldwide. Pulmonary (TB) commonly seen presentation; however, TB can affect nearly any body's organ systems. Endobronchial (EBTB) complicate pulmonary or more rarely present as an isolated finding. It essential to recognize treat this condition promptly, it develop into tracheobronchial stenosis chronic...

10.7759/cureus.17173 article EN Cureus 2021-08-14
Coming Soon ...